Sodium thiosulfate: Mythical treatment for a mysterious disease?

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 7, 2013, Pages 1068-1069

  O'Neill, W Charles ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; HYDROXYAPATITE; SODIUM THIOSULFATE; VITAMIN D; WARFARIN;

ARTERY CALCIFICATION; CALCIFIC UREMIC ARTERIOLOPATHY; CALCINOSIS; CALCIUM BLOOD LEVEL; EDITORIAL; HUMAN; KIDNEY FAILURE; MINERAL METABOLISM; NAUSEA AND VOMITING; NEPHROLITHIASIS; NONHUMAN; PARATHYROIDECTOMY; PREVALENCE; RISK FACTOR;

CALCIPHYLAXIS; FEMALE; HUMANS; MALE; THIOSULFATES;

EID: 84879820713     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04990513     Document Type: Editorial

References (16)

1. Duhn V, D'Orsi ET, Johnson S, D'Orsi CJ, Adams AL, O'Neill WC: Breast arterial calcification: A marker of medial vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 6: 377-382, 2011.
2. International Collaborative Calciphylaxis Network (ICCN): International Collaborative Calciphylaxis Network. Available at: http://www.calciphylaxis.org.uk/. Accessed May 13, 2013.
3. Essary LR, Wick MR: Cutaneous calciphylaxis. An underrecognized clinicopathologic entity. Am J Clin Pathol 113: 280-287, 2000.
4. Brandenburg VM, Cozzolino M, Ketteler M: Calciphylaxis: A still unmet challenge. J Nephrol 24: 142-148, 2011.
5. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO: Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60: 324-332, 2001.
6. Fine A, Zacharias J: Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 61: 2210-2217, 2002.
7. Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y; Japanese Calciphylaxis Study Group: A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27: 1580-1584, 2012.
8. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997.
9. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23: 63-67, 1985.
10. Yatzidis H, Agroyannis B: Sodium thiosulfate treatment of soft tissue calcifications in patients with end-stage renal disease. Perit Dial Int 7: 250-252, 1987.
11. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108, 2004.
12. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74: 1444-1453, 2008.
13. O'Neill WC, Hardcastle KI: The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant 27: 521-526, 2012.
14. Lomashvili K, Garg P, O'Neill WC: Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 69: 1464-1470, 2006.
15. Mendoza FJ, Lopez I, Montes de Oca A, Perez J, Rodriguez M, Aguilera-Tejero E: Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 73: 407-414, 2008.
16. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr: Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol 8: 1162-1170, 2013